JPMorgan Downgrades Dyne Therapeutics (DYN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| DYNEGY, Inc. (NASDAQ: DYN) | Delayed: 18.54 +0.49 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.05 | 52 Week High | $22.01 | |||
| Open | $18.57 | 52 Week Low | $7.01 | |||
| Day High | $19.00 | P/E | N/A | |||
| Day Low | $17.94 | EPS | $0.00 | |||
| Volume | 3,649,278 | |||||
